Ekhinos OÜ

Active Registry code 16580362 OÜ Tartu linn Registered 26 Sep 2022
Compare

Ekhinos OÜ is a OÜ based in Tartu linn, registry code 16580362, status: active. Main activity: Research and experimental development on biotechnology. Its annual report for 2025 shows revenue of €0 and 0 employees.

Turnover
—
State taxes
448 €
Labour taxes
0 €
Employees
—

Q1 2024 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q1 2024 – Q1 2024
State taxes, € Q1 2024: 448 €
0100200300400500Q1 2024 Company: 448 €Q1·240100200300400500Q1 2024 Company: 448 €Q1·24
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q1 2024 — 448 — —

Financials by year

2022 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
05001 0001 5002 0002022 Company: 1 798 € Industry median: 103 €20222023 Company: 1 735 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €202505001 0001 5002 0002022 Company: 1 798 € Industry median: 103 €2023 Company: 1 735 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -1 500 € · −850.0% vs 2024 · industry median 0 € · above 19% of the industry
-2 000-1 00001 0002 0002022 Company: 1 791 € Industry median: 0 €20222023 Company: 1 905 € Industry median: 0 €20232024 Company: 200 € Industry median: 0 €20242025 Company: -1 500 € Industry median: 0 €2025-2 000-1 00001 0002 0002022 Company: 1 791 € Industry median: 0 €2023 Company: 1 905 € Industry median: 0 €20232024 Company: 200 € Industry median: 0 €2025 Company: -1 500 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2023: 109.8 % · +10.2 pp vs the year before · industry median 16.8 % · above 98% of the industry
02550751001252022 Company: 99.6 % Industry median: 17.7 %20222023 Company: 109.8 % Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %20242025 Company: — Industry median: 13.5 %202502550751001252022 Company: 99.6 % Industry median: 17.7 %2023 Company: 109.8 % Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %2025 Company: — Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 11 330 € · −11.7% vs 2024
05 00010 00015 0002022 Company: 4 291 €20222023 Company: 12 630 €20232024 Company: 12 830 €20242025 Company: 11 330 €202505 00010 00015 0002022 Company: 4 291 €2023 Company: 12 630 €20232024 Company: 12 830 €2025 Company: 11 330 €2025
Equity, € 2025: 3 105 € · −32.6% vs 2024
01 0002 0003 0004 0005 0002022 Company: 4 291 €20222023 Company: 4 405 €20232024 Company: 4 605 €20242025 Company: 3 105 €202501 0002 0003 0004 0005 0002022 Company: 4 291 €2023 Company: 4 405 €20232024 Company: 4 605 €2025 Company: 3 105 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 -1 500 0 11 330 3 105 0
2024 0 200 0 12 830 4 605 0
2023 1 735 1 905 0 12 630 4 405 0
2022 1 798 1 791 0 4 291 4 291 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-48.3 %
Net profit / equity
Return on assets (ROA)
-13.2 %
Net profit / assets
Equity ratio
27.4 %
Equity / assets
Debt ratio
72.6 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 29 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 28 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 28 Jun 2024 Company’s own e-Äriregister
2022 26 Sep 2022 – 31 Dec 2022 26 Jun 2023 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Owner in

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 7211Research and experimental development on biotechnology Main

Rulings 2

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50211509 / 2
1 Sep 2023
 Amendment entry In force
1 Sep 2023
 PDF
Ä 50211509
26 Sep 2022
 First entry In force
26 Sep 2022
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data